SCHEMBL3578694

SCHEMBL3578694

CCCNC(=O)[C@H]1CCC[C@H]1N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 1/20 0.48
EPHX1 P07099 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
NAAA Q02083 1/20 0.40
CHRNB2 P17787 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA7 P36544 1/20 0.40
CHRNA4 P43681 1/20 0.40
PSEN1 P49768 1/20 0.39
PSEN2 P49810 1/20 0.39
APH1B Q8WW43 1/20 0.39
NCSTN Q92542 1/20 0.39
APH1A Q96BI3 1/20 0.39
PSENEN Q9NZ42 1/20 0.39
LMNA P02545 1/20 0.38
POLB P06746 2/20 0.37
PRCP P42785 1/20 0.36
BCHE P06276 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2521351 1.00 GRM4 (0.48) GRM4EPHX1KDM4EALDH1A1NAAA
SCHEMBL4295164 0.89 CHRNB2 (0.46) GRM4EPHX1KDM4EALDH1A1NAAA
SCHEMBL11616912 0.86 NAAA (0.53) EPHX1NAAAPOLBPRCP
SCHEMBL11616910 0.86 NAAA (0.53) EPHX1NAAAPOLBPRCP
SCHEMBL16767823 0.84 PSEN1 (0.44) GRM4KDM4EPSEN1PSEN2APH1B
SCHEMBL21253759 0.84 MC4R (0.39) ALDH1A1PSEN1PSEN2APH1BNCSTN
SCHEMBL18273734 0.81 SIGMAR1 (0.37) GRM4PSEN1PSEN2APH1BNCSTN
SCHEMBL18273730 0.81 SIGMAR1 (0.37) GRM4PSEN1PSEN2APH1BNCSTN
SCHEMBL18273732 0.80 PSEN1 (0.36) GRM4EPHX1PSEN1PSEN2APH1B
SCHEMBL4598377 0.80 TAAR1 (0.40) GRM4ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8623887-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-01-07 US disclosed
US-8466318-B2 Method of preparing chiral cyclic β-aminocarboxamides BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-18 US disclosed
EP-2109605-B1 2- [(PHENYLAMINO) -PYRIMIDIN-4YLAMIN0] -CYCLOPENTANE CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF KINASES OF THE CELL CYCLE FOR THE TREATMENT OF CANCER BOEHRINGER INGELHEIM INT (DE) 2013-02-20 EP disclosed
EP-2027083-B1 METHOD OF PREPARING CHIRAL CYCLIC BETA-AMINOCARBOXAMIDES BOEHRINGER INGELHEIM INT (DE) 2012-07-11 EP disclosed
US-20100144706-A1 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-06-10 US disclosed
US-20090209787-A1 METHOD OF PREPARING CHIRAL CYCLIC BETA-AMINOCARBOXAMIDES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-08-20 US disclosed
US-20090163467-A1 New compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144706-A1 Compounds MKI67, CCNA1, CCNT1 GRM4 2671/4885EPHX1 443/4885KDM4E 1828/4885
US-20090209787-A1 METHOD OF PREPARING CHIRAL CYCLIC BETA-AMINOCARBOXAMIDES PRMT1, CCNT1, CCNA1 GRM4 2463/4885EPHX1 671/4885KDM4E 716/4885
US-20090163467-A1 New compounds CCNA1, MKI67, CCNT1 GRM4 3393/4885EPHX1 721/4885KDM4E 2552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.